Julie R. Brahmer, MD | Authors


Clarifying Mechanisms of Resistance May Enhance Treatment Strategies

November 14, 2019

Although immune checkpoint inhibitor therapy has represented a paradigm shift in the treatment of multiple types of cancer, many patients’ cancers do not respond at all to these therapies or develop resistance after an initial period of response, according to Julie R. Brahmer, MD.